Botulinum Toxin Injection Into Epicardial Fat Pads to Prevent Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT02617069 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

170

Enrollment

NETWORK

Sponsor class

Conditions

Atrial Fibrillation

Interventions

BIOLOGICAL: botulinum toxin injection
BIOLOGICAL: 0.9% normal saline injection
DEVICE: Implantable loop recorder

Sponsor

Meshalkin Research Institute of Pathology of Circulation